AKT1 and cancer: Studies have illustrated that the activation of PI3K‐AKT‐mTOR pathway and autophagy44, 45, 46 and the inactivation of pro‐apoptotic caspase pathway47, 48 are involved in the therapeutic resistance for cancers.